
Once-Monthly Oral PrEP Moves into Phase III Trials
An investigational once-monthly pill holds promise for HIV pre-exposure prophylaxis (PrEP), according to mid-stage study results presented yesterday at the International AIDS Society Conference on HIV Science (IAS 2025) in Rwanda. With favorable …